Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Staphylococcus aureus subsp. aureus RN4220

ABSTRACT: Staphylococcus aureus subsp. aureus RN4220 genome sequencing project

PROVIDER: PRJNA66527 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Staphylococcus aureus subsp. aureus RN4220 isolate:RN4220

Project description:Staphylococcus aureus subsp. aureus RN4220 isolate:RN4220 Genome sequencing

| PRJNA733837 | ENA

Staphylococcus aureus subsp. aureus RN4220

Project description:Staphylococcus aureus subsp. aureus RN4220 Genome sequencing

| PRJNA1091562 | ENA

Staphylococcus aureus subsp. aureus RN4220

Project description:Staphylococcus aureus subsp. aureus RN4220 Genome sequencing and assembly

| PRJNA598506 | ENA

Staphylococcus aureus subsp. aureus RN4220

Project description:Staphylococcus aureus RN4220 SaoC regulon

| PRJNA798259 | ENA

Staphylococcus aureus RN4220 wild-type extracellular vesicle proteome

Project description:Bacteria actively secrete extracellular vesicles (EVs), spherical nano-sized proteolipids into the extracellular milieu. Bacterial EVs have gained wide interests as non-living complex vaccines or delivery vehicles. However, no studies have used bacterial EVs in treating cancer so far. Our results showed remarkable capability of EVs derived from Staphylococcus aureus RN4220 wild-type to effectively induce long-term anti-tumor immune responses that can fully eradicate established tumors without notable adverse effects. This anti-tumor effect was IFN-γ-dependent, and we present a comprehensive proteome of S. aureus RN4220 wild-type EVs to investigate which vesicular components induce the anti-tumor effects.

2018-11-22 | PXD006913 | Pride

RNA-seq reveals differential gene expression in Staphylococcus aureus at single-nucleotide resolution

Project description:Staphylococcus aureus is a gram-positive cocci and an important human commensal bacteria and pathogen. S. aureus infections are increasingly difficult to treat because of the emergence of highly resistant MRSA (Methicillin-resistant S. aureus) strains. Here we present a method to study differential gene expression in S. aureus using high-throughput RNA-sequencing (RNA-seq). We use RNA-seq to examine the differential gene expression in S. aureus RN4220 cells containing an exogenously expressed transcription factor and between two S. aureus strains (RN4220 and NCTC8325-4). The information provided by RNA-seq was a significant advance over previously described microarray based techniques. We investigated the sequence and gene expression differences between RN4220 and NCTC8325-4 and used the RNA-seq data to identify S. aureus promoters suitable for in vitro analysis. We used RNA-seq to describe, on a genome wide scale, genes positively and negatively regulated by a phage encoded transcription factor, gp67. RNA-seq offers the ability to study differential gene expression with single-nucleotide resolution, and is a considerable improvement over the predominant genome-wide transcriptome technologies used in S. aureus. RNA-seq analysis of Staphylococcus aureus RN4220 (electrocompetent strain) carrying either empty pRMC2 (inducible expression vector) or pRMC2 carrying the ORF67 gene (encodes gp67). Both strains were grown to OD 0.2 and transgene expression was induced with 100ng/ml anhydrotetracycline. As a control, Staphylococcus aureus strain NCTC8325-4 (non-electrocompetent strain) was grown under identical conditions except without the addition of anhydrotetracycline.

2013-11-07 | E-GEOD-48896 | biostudies-arrayexpress

Staphylococcus aureus subsp. aureus RN4220

Project description:Differences in gene expression of delta-fmt and wild-type Staphylococcus aureus RN4220

| PRJNA178011 | ENA

RNA-seq reveals differential gene expression in Staphylococcus aureus at single-nucleotide resolution

2013-11-07 | GSE48896 | GEO

Staphylococcus aureus subsp. aureus RN4220

Project description:Staphylococcus aureus genome sequencing

| PRJNA362828 | ENA

Staphylococcus aureus subsp. aureus C101

Project description:Staphylococcus aureus subsp. aureus C101 genome sequencing project

| PRJNA39227 | ENA